Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis

被引:321
|
作者
Goto, Atsushi [1 ,2 ]
Arah, Onyebuchi A. [3 ,4 ]
Goto, Maki [1 ,2 ]
Terauchi, Yasuo [2 ]
Noda, Mitsuhiko [1 ]
机构
[1] Natl Ctr Global Hlth & Med, Diabet Res Ctr, Dept Diabet Res, Shinjuku Ku, Tokyo 1628655, Japan
[2] Yokohama City Univ, Grad Sch Med, Dept Endocrinol & Metab, Yokohama, Kanagawa 232, Japan
[3] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA USA
[4] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands
来源
关键词
AMERICAN-DIABETES-ASSOCIATION; GLUCOSE CONTROL; INCREASED RISK; SENSITIVITY-ANALYSIS; TYPE-2; MORTALITY; MELLITUS; EVENTS; VETERANS; CANCER;
D O I
10.1136/bmj.f4533
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To provide a systematic and quantitative summary of the association between severe hypoglycaemia and risk of cardiovascular disease in people with type 2 diabetes and to examine the sensitivity of the association to possible uncontrolled confounding by unmeasured comorbid severe illness using a bias analysis. Design Meta-analysis of observational studies. Data sources Medline, Embase, the Cochrane Library, and Web of Science databases were searched to February 2013, without any language restrictions. Eligibility criteria Two independent reviewers selected cohort studies that evaluated the association of severe hypoglycaemia with cardiovascular events in people with type 2 diabetes; we excluded studies from acute hospital settings. We extracted descriptive and quantitative data. Results Of 3443 citations screened, six eligible studies with 903 510 participants were identified. In the conventional random effects meta-analysis, severe hypoglycaemia was strongly associated with a higher risk of cardiovascular disease (relative risk 2.05, 95% confidence interval 1.74 to 2.42; P<0.001). The excess fraction of cardiovascular disease incidence that was attributable to severe hypoglycaemia (the population attributable fraction) was 1.56% (95% confidence interval 1.32% to 1.81%; P<0.001). Although moderate heterogeneity across the studies was suggested (I-2=73.1%; P=0.002 for heterogeneity), most subgroups showed similar results in stratified analyses. The bias analysis indicated that comorbid severe illness alone may not explain the association between hypoglycaemia and cardiovascular disease; to explain this association, comorbid severe illness would have had to be extremely strongly associated with both severe hypoglycaemia and cardiovascular disease. Conclusion Our findings suggest that severe hypoglycaemia is associated with a higher risk of cardiovascular disease; they also support the notion that avoiding severe hypoglycaemia may be important to prevent cardiovascular disease in people with type 2 diabetes.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Peanut and cardiovascular disease risk factors: A systematic review and meta-analysis
    Azad, Banafsheh
    Daneshzad, Elnaz
    Azadbakht, Leila
    CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2020, 60 (07) : 1123 - 1140
  • [32] Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular Disease
    Micha, Renata
    Imamura, Fumiaki
    von Ballmoos, Moritz Wyler
    Solomon, Daniel H.
    Hernan, Miguel A.
    Ridker, Paul M.
    Mozaffarian, Dariush
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 108 (09): : 1362 - 1370
  • [33] Role of Influenza Vaccination in Cardiovascular Disease: Systematic Review and Meta-Analysis
    Gupta, Rahul
    Quy, Ray
    Lin, Muling
    Mahajan, Pranav
    Malik, Aaqib
    Sood, Aayushi
    Sreenivasan, Jayakumar
    Bandyopadhyay, Dhrubajyoti
    Goel, Akshay
    Agrawal, Ankit
    Vyas, Apurva V.
    Patel, Nainesh C.
    Frishman, William H.
    Aronow, Wilbert S.
    CARDIOLOGY IN REVIEW, 2024, 32 (05) : 423 - 428
  • [34] Depression prevalence in cardiovascular disease: global systematic review and meta-analysis
    Rafiei, Sima
    Raoofi, Samira
    Baghaei, Aryan
    Masoumi, Maryam
    Doustmehraban, Maryam
    Nejatifar, Zahra
    Sanaei, Mohaddeseh
    Bagheribayati, Farzaneh
    Shahrebabak, Elahe Sadat Vaziri
    Shayestehbonyan, Maral
    Biparva, Akbar Javan
    Raoofi, Neda
    Mir, Maryam
    Momeni, Zeinab
    Yousefy, Sama
    Khoonigh, Zahra Hashemi
    Rezaei, Fatemeh
    Kan, Fatemeh Pashazadeh
    Ghashghaee, Ahmad
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2023, 13 (03) : 281 - 289
  • [35] Aliskiren therapy in hypertension and cardiovascular disease: a systematic review and a meta-analysis
    Fu, Shufang
    Wen, Xin
    Han, Fei
    Long, Yin
    Xu, Gaosi
    ONCOTARGET, 2017, 8 (51) : 89364 - 89374
  • [36] The Role of Niacin in Cardiovascular Disease Prevention: A Systematic Review and Meta-analysis
    D'Andrea, Elvira
    Hey, S.
    Ramirez, C. L.
    Kesselheim, A.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2019, 29 : 139 - 139
  • [37] Efficacy of telemedicine for the management of cardiovascular disease: a systematic review and meta-analysis
    Kuan, Pei Xuan
    Chan, Weng Ken
    Ying, Denisa Khoo Fern
    Rahman, Mohd Aizuddin Abdul
    Peariasamy, Kalaiarasu M.
    Lai, Nai Ming
    Mills, Nicholas L.
    Anand, Atul
    LANCET DIGITAL HEALTH, 2022, 4 (09): : E676 - E691
  • [38] Sexual violence and cardiovascular disease risk: A systematic review and meta-analysis
    Jakubowski, Karen P.
    Murray, Vanessa
    Stokes, Natalie
    Thurston, Rebecca C.
    MATURITAS, 2021, 153 : 48 - 60
  • [39] Polypills for Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis
    Kandil, Omneya A.
    Motawea, Karam R.
    Aboelenein, Merna M.
    Shah, Jaffer
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [40] Use of MHT in women with cardiovascular disease: a systematic review and meta-analysis
    Bontempo, S.
    Yeganeh, L.
    Giri, R.
    Vincent, A. J.
    CLIMACTERIC, 2024, 27 (01) : 93 - 103